SIETES :: 93059 citas

Resultados de la búsqueda por PERINDOPRIL REFINAR BÚSQUEDA

1.

Azzouz B, Morel A, Kanagaratman L, Herlem E, Trenque T. Psoriasis after exposure to angiotensin-converting enzyme inhibitors: French pharmacovigilance data and review of the literature. Drug Saf 2019;42:diciembre. [Ref.ID 103209]

2.

Bangalore S, Fakheri R, Wandel S, Toklu B, Wandel J, Messerli FH. Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials. BMJ 2017;356:j4. [Ref.ID 101389]

3.

Cressman AM, Macdonald EM, Fernandes KA, Gomes T, Paterson JM, Mamdani MM, Juurlink DN, for the Canadian Drug Safety Effectiveness Research Network (CDSERN). A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors. Br J Clin Pharmacol 2015;80:662-9. [Ref.ID 99608]

4.

Anónimo. Traitement de l'hypertension artérielle essentielle. Un diurétique thiazidique en premier choix, le plus souvent. Prescrire 2014;34:275-81. [Ref.ID 97442]

5.

Gao Y, O'Caoimh R, Healy L, Kerins DM, Eustace J, Guyatt G, Sammon D, Molloy DW. Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia. BMJ Open 2013;3:22 de julio. [Ref.ID 95839]

6.

Savarese G, Costanzo P, Cleland JGF, Vassallo E, Ruggiero D, Rosano G, Perrone-Filardi P. A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure. J Am Coll Cardiol 2013;61:131-42. [Ref.ID 94624]

7.

Anónimo. Candesartan, fetal malformations and use in pregnancy. Australian Prescriber 2012;35:98. [Ref.ID 92635]

8.

van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad J-J, Boersma E. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiontensin-aldosterone system inhibitors involving 158 998 patients. Eur Heart J 2012;33:2088-97. [Ref.ID 92621]

9.

Beckett N, Peters R, Tuomilehto J, Swift C, Sever P, Potter J, McCormack T, Forette F, Gil-Extremera B, Dumitrascu D, Staessen JA, Thijs L, Fletcher A, Bulpitt C, for the HYVET Study Group. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ 2012;344:16. [Ref.ID 92218]

10.

Mancia G. Antihypertensives in octogenarians. BMJ 2012;344:8. [Ref.ID 92214]

11.

Arroll B, Doughty R, Andersen V. Investigation and management of congestive heart failure. BMJ 2010;341:190-5. [Ref.ID 88929]

12.

Emery J, McKenzie A, Bulsara C, Holman D'Arcy. Next goal: consistency of packaging and labelling. BMJ 2010;341:64. [Ref.ID 88869]

13.

Bonet Monné S. Dades d'eficàcia dels IECA, ARA II i la combinació d'ambdós grups de fàrmacs. Butlletí d'Informació Terapèutica 2010;22:7-12. [Ref.ID 88270]

14.

Hughes D, Ferner R. New drugs for old: disinvestment and NICE. BMJ 2010;340:690-2. [Ref.ID 88185]

15.

Montero Corominas D, García del Pozo J, de Abajo FJ. Utilización de antihipertensivos en España, 1992-2006. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2009:1-14. [Ref.ID 86455]

16.

Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Golf Jr DC. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension. Results from the Cardiovascular Health Study. Arch Intern Med 2009;169:1195-202. [Ref.ID 86332]

17.

Suissa S. Calculation of number needed to treat. N Engl J Med 2009;361:424-5. [Ref.ID 86302]

18.

Krum H, Abraham WT. Heart failure. Lancet 2009;373:941-55. [Ref.ID 85474]

19.

Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, Woodward M, Cooper M, Harrap S, Hamet P, Poulter N, Lip GYH, Patel A, on behalf of the ADVANCE Collaborative Group. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J 2009;30:1128-35. [Ref.ID 85434]

20.

Tannen RL, Weiner MG, Xie D. Use of primary care electronic medical record database drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled findings. BMJ 2009;338:395-9. [Ref.ID 85269]